Thank you nickeefe0404. I agree with your assessment of a strong buy but am somewhat concerned about the failure of their most recent drug on which they had based high hopes for replacing Humira. The Hep C drug appears very promising though. I think I might switch to the medical instruments (ABBV?) side to begin with until the drug side becomes more clear.